|
MORC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06240000019575E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.56540000020955E-07 |
| Normal-vs-Stage2 |
7.520000E-03 |
| Normal-vs-Stage3 |
4.153300E-04 |
| Normal-vs-Stage4 |
4.94780000004358E-06 |
| Stage1-vs-Stage2 |
5.117600E-01 |
| Stage1-vs-Stage3 |
3.151600E-01 |
| Stage1-vs-Stage4 |
4.212600E-01 |
| Stage2-vs-Stage3 |
9.541800E-01 |
| Stage2-vs-Stage4 |
2.874600E-01 |
| Stage3-vs-Stage4 |
1.359040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.18320000025629E-07 |
| Normal-vs-AfricanAmerican |
3.951600E-04 |
| Normal-vs-Asian |
4.12260000004494E-06 |
| Caucasian-vs-AfricanAmerican |
5.978000E-01 |
| Caucasian-vs-Asian |
1.262400E-02 |
| AfricanAmerican-vs-Asian |
4.483700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07519999995132E-06 |
| Normal-vs-Female |
5.79540000433809E-08 |
| Male-vs-Female |
1.063580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.985630E-02 |
| Normal-vs-Age(41-60Yrs) |
2.08720000172136E-08 |
| Normal-vs-Age(61-80Yrs) |
1.51451999998997E-05 |
| Normal-vs-Age(81-100Yrs) |
2.636600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.338600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.709200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.603200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.490620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.089900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.918640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.37860000004597E-06 |
| Normal-vs-Grade 2 |
4.11459999960506E-07 |
| Normal-vs-Grade 3 |
1.65305999999532E-05 |
| Normal-vs-Grade 4 |
7.68620000000109E-05 |
| Grade 1-vs-Grade 2 |
6.379500E-02 |
| Grade 1-vs-Grade 3 |
2.706300E-02 |
| Grade 1-vs-Grade 4 |
7.268100E-02 |
| Grade 2-vs-Grade 3 |
4.583000E-01 |
| Grade 2-vs-Grade 4 |
9.155600E-01 |
| Grade 3-vs-Grade 4 |
5.150400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.42240000070515E-08 |
| Normal-vs-ccB subtype |
2.613600E-04 |
| ccA subtype-vs-ccB subtype |
7.825700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.19169999996038E-06 |
| Normal-vs-N1 |
2.759300E-04 |
| N0-vs-N1 |
1.794600E-01 |
|
|
